Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | HTR2B | P41595 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | ADK | P55263 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31650964 | 0.97 | ALDH1A1 (0.56) | ALDH1A1CA2RAB9ASLC6A3KDM4E | |
| SCHEMBL28452557 | 0.95 | ALDH1A1 (0.54) | ALDH1A1CA2RAB9ASLC6A3KDM4E | |
| SCHEMBL7646016 | 0.87 | ALDH1A1 (0.44) | ALDH1A1CA2RAB9ASLC6A3KDM4E | |
| SCHEMBL7641536 | 0.87 | ALDH1A1 (0.44) | ALDH1A1CA2RAB9ASLC6A3KDM4E | |
| SCHEMBL979938 | 0.87 | ALDH1A1 (0.44) | ALDH1A1CA2RAB9ASLC6A3KDM4E | |
| SCHEMBL28543654 | 0.82 | ALDH1A1 (0.49) | ALDH1A1CA2RAB9ASLC6A3KDM4E | |
| SCHEMBL28541786 | 0.82 | TNKS (0.43) | ALDH1A1CA2RAB9ASLC6A3KDM4E | |
| SCHEMBL28542569 | 0.82 | KMT2A (0.47) | ALDH1A1CA2RAB9ASLC6A3KDM4E | |
| SCHEMBL28541756 | 0.82 | ALDH1A1 (0.49) | ALDH1A1CA2RAB9ASLC6A3KDM4E | |
| SCHEMBL1923907 | 0.81 | ALDH1A1 (0.47) | ALDH1A1CA2RAB9ASLC6A3KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109553709-B | Catalyst component for olefin polymerization and catalyst thereof | 中国石油化工股份有限公司 | 2021-04-13 | — | — | CN | claimed |
| CN-109553708-B | Catalyst component for olefin polymerization and preparation method thereof | 中国石油化工股份有限公司 | 2021-04-13 | — | — | CN | claimed |
| CN-109553707-B | Catalyst component for olefin polymerization, catalyst and application | 中国石油化工股份有限公司 | 2021-04-09 | — | — | CN | claimed |
| EP-4747306-A1 | THERMALLY CONDUCTIVE TWO-COMPONENT COMPOSITION WITH CURING RETARDER | Sika Technology AG (CH) | 2026-05-27 | — | — | EP | disclosed |
| EP-4724511-A1 | THERMALLY CONDUCTIVE CURABLE COMPOSITION | Sika Technology AG (CH) | 2026-04-15 | — | — | EP | disclosed |
| EP-4133018-B1 | CURABLE COMPOSITIONS BASED ON SILANE-FUNCTIONAL POLYMERS OVERPAINTABLE | SIKA TECH AG (CH) | 2026-01-21 | — | — | EP | disclosed |
| EP-3861041-B1 | HARDENABLE COMPOSITION WITH LOW DENSITY | SIKA TECH AG (CH) | 2026-01-07 | — | — | EP | disclosed |
| EP-3924412-B1 | THERMALLY CONDUCTIVE CURABLE COMPOSITION | SIKA TECH AG (CH) | 2025-12-10 | — | — | EP | disclosed |
| EP-4545596-A2 | A THERMOPLASTIC COMPOSITION HAVING IMPROVED MECHANICAL PROPERTIES | Sika Technology AG (CH) | 2025-04-30 | — | — | EP | disclosed |
| EP-4176004-B1 | A THERMOPLASTIC COMPOSITION HAVING IMPROVED MECHANICAL PROPERTIES | SIKA TECH AG (CH) | 2025-03-12 | — | — | EP | disclosed |
| WO-2025017022-A1 | THERMALLY CONDUCTIVE TWO-COMPONENT COMPOSITION WITH CURING RETARDER | SIKA TECHNOLOGY AG (CH) | 2025-01-23 | — | — | WO | disclosed |
| US-20070142461-A1 | Cyclic alkyl substituted glycolides and polylactides therefrom | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2007-06-21 | — | — | US | disclosed |
| US-20070142461-A1 | Cyclic alkyl substituted glycolides and polylactides therefrom | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2007-06-21 | — | — | US | disclosed |
| EP-1774410-A1 | CHARGE CONTROL AGENT, TONER, IMAGE FORMING METHOD, AND IMAGE FORMING APPARATUS | Canon Kabushiki Kaisha (JP) | 2007-04-18 | — | — | EP | disclosed |
| US-20060247414-A1 | Polyhydroxyalkanoate having vinyl group, ester group, carboxyl group and sulfonic acid group, and production method thereof | CANON KABUSHIKI KAISHA (JP) | 2006-11-02 | — | — | US | disclosed |
| WO-2005121904-A1 | CHARGE CONTROL AGENT, TONER, IMAGE FORMING METHOD, AND IMAGE FORMING APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2005-12-22 | — | — | WO | disclosed |
| US-5326887-A | Reacting ester of alpha hydroxy acid oligomer over fixed bed catalyst | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-07-05 | — | — | US | disclosed |
| EP-0586575-A1 | DEGRADABLE CELLULOSE POLYMERS | BATTELLE MEMORIAL INSTITUTE (US) | 1994-03-16 | — | — | EP | disclosed |
| WO-1992020738-A1 | DEGRADABLE CELLULOSE POLYMERS | BATTELLE MEMORIAL INSTITUTE (US) | 1992-11-26 | — | — | WO | disclosed |
| WO-1992015572-A1 | PROCESS FOR THE PREPARATION OF 1,4-DIOXANE-2,5-DIONES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-09-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070142461-A1 | Cyclic alkyl substituted glycolides and polylactides therefrom | UGCG, DDOST, MAGT1 | ALDH1A1 4084/4885CA2 2871/4885RAB9A 2827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.